196 related articles for article (PubMed ID: 28435530)
1. Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX.
Hutchinson JH; Rowbottom MW; Lonergan D; Darlington J; Prodanovich P; King CD; Evans JF; Bain G
ACS Med Chem Lett; 2017 Apr; 8(4):423-427. PubMed ID: 28435530
[TBL] [Abstract][Full Text] [Related]
2. LOXL2 Inhibitors and Breast Cancer Progression.
Ferreira S; Saraiva N; Rijo P; Fernandes AS
Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33669630
[TBL] [Abstract][Full Text] [Related]
3. Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2).
Rowbottom MW; Bain G; Calderon I; Lasof T; Lonergan D; Lai A; Huang F; Darlington J; Prodanovich P; Santini AM; King CD; Goulet L; Shannon KE; Ma GL; Nguyen K; MacKenna DA; Evans JF; Hutchinson JH
J Med Chem; 2017 May; 60(10):4403-4423. PubMed ID: 28471663
[TBL] [Abstract][Full Text] [Related]
4. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
[TBL] [Abstract][Full Text] [Related]
5. LOXL2 small molecule inhibitor restrains malignant transformation of cervical cancer cells by repressing
Peng T; Lin S; Meng Y; Gao P; Wu P; Zhi W; Ding W; Cao C; Wu P
Cell Cycle; 2022 Sep; 21(17):1827-1841. PubMed ID: 35509127
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer.
Chang J; Lucas MC; Leonte LE; Garcia-Montolio M; Singh LB; Findlay AD; Deodhar M; Foot JS; Jarolimek W; Timpson P; Erler JT; Cox TR
Oncotarget; 2017 Apr; 8(16):26066-26078. PubMed ID: 28199967
[TBL] [Abstract][Full Text] [Related]
7. Purification of enzymatically active human lysyl oxidase and lysyl oxidase-like protein from Escherichia coli inclusion bodies.
Jung ST; Kim MS; Seo JY; Kim HC; Kim Y
Protein Expr Purif; 2003 Oct; 31(2):240-6. PubMed ID: 14550642
[TBL] [Abstract][Full Text] [Related]
8. Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3.
Findlay AD; Foot JS; Buson A; Deodhar M; Jarnicki AG; Hansbro PM; Liu G; Schilter H; Turner CI; Zhou W; Jarolimek W
J Med Chem; 2019 Nov; 62(21):9874-9889. PubMed ID: 31580073
[TBL] [Abstract][Full Text] [Related]
9. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
[TBL] [Abstract][Full Text] [Related]
10. The role of LOX and LOXL2 in scar formation after glaucoma surgery.
Van Bergen T; Marshall D; Van de Veire S; Vandewalle E; Moons L; Herman J; Smith V; Stalmans I
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5788-96. PubMed ID: 23821193
[TBL] [Abstract][Full Text] [Related]
11. Detection of Lysyl Oxidase-Like 2 (LOXL2), a Biomarker of Metastasis from Breast Cancers Using Human Blood Samples.
Janyasupab M; Lee YH; Zhang Y; Liu CW; Cai J; Popa A; Samia AC; Wang KW; Xu J; Hu CC; Wendt MK; Schiemann BJ; Thompson CL; Yen Y; Schiemann WP; Liu CC
Recent Pat Biomark; 2015; 5(2):93-100. PubMed ID: 28670509
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidases: a novel multifunctional amine oxidase family.
Csiszar K
Prog Nucleic Acid Res Mol Biol; 2001; 70():1-32. PubMed ID: 11642359
[TBL] [Abstract][Full Text] [Related]
13. Lysyl Oxidases Expression and Breast Cancer Progression: A Bioinformatic Analysis.
Ramos S; Ferreira S; Fernandes AS; Saraiva N
Front Pharmacol; 2022; 13():883998. PubMed ID: 35800439
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.
Okada K; Moon HJ; Finney J; Meier A; Mure M
Biochemistry; 2018 Dec; 57(51):6973-6983. PubMed ID: 30499665
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state.
Zhang X; Wang Q; Wu J; Wang J; Shi Y; Liu M
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3828-3833. PubMed ID: 29581294
[TBL] [Abstract][Full Text] [Related]
16. Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts.
Mižíková I; Palumbo F; Tábi T; Herold S; Vadász I; Mayer K; Seeger W; Morty RE
Physiol Genomics; 2017 Aug; 49(8):416-429. PubMed ID: 28698228
[TBL] [Abstract][Full Text] [Related]
17. The Expression Patterns and Roles of Lysyl Oxidases in Aortic Dissection.
Yi X; Zhou Y; Chen Y; Feng X; Liu C; Jiang DS; Geng J; Li X; Jiang X; Fang ZM
Front Cardiovasc Med; 2021; 8():692856. PubMed ID: 34307505
[No Abstract] [Full Text] [Related]
18. Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB.
Mahjour F; Dambal V; Shrestha N; Singh V; Noonan V; Kantarci A; Trackman PC
Oncogenesis; 2019 May; 8(5):34. PubMed ID: 31086173
[TBL] [Abstract][Full Text] [Related]
19. The Role of LOX and LOXL2 in the Pathogenesis of an Experimental Model of Choroidal Neovascularization.
Van Bergen T; Spangler R; Marshall D; Hollanders K; Van de Veire S; Vandewalle E; Moons L; Herman J; Smith V; Stalmans I
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5280-9. PubMed ID: 26258612
[TBL] [Abstract][Full Text] [Related]
20. Lysyl Oxidase-like 2 Dysregulation Increases the Risk of Post-Operative Fibrotic Scars Formation in the Female Reproductive Tract: A Novel Therapeutic Target to Reduce Fibrogenesis.
Khodashahi R; Dehkordi S; Ahmadzade AM; Ferns GA; Aliakbarian M; Arjmand MH
Curr Med Chem; 2024 Jun; ():. PubMed ID: 38939993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
